Self-administration of epoetin beta by peritoneal dialysis patients
York, S.; Kinney, R.; Taber, T.E.
Anna Journal 18(6): 549-552
1991
ISSN/ISBN: 8750-0779 PMID: 1750786 Document Number: 376684
Recombinant human erythropoietin (epoetin) reverses the anemia of end stage renal disease. Benefits have been evaluated primarily in hemodialysis patients because of the ease of administration via existing intravenous access. Studies are under way to evaluate the feasibility of subcutaneous self-administration of epoetin in continuous ambulatory peritoneal dialysis (CAPD) patients. Preliminary study results, using the maintenance of target hemoglobin levels to measure success and a case study demonstrate the practicality of subcutaneous self-administration of epoetin in CAPD patients.
Document emailed within 1 workday
Related Documents
Ito, C.; Akimoto, T.; Morishita, Y.; Yamamoto, H.; Ogura, M.; Yamazaki, T.; Miki, A.; Homma, S.; Kusano, E.; Asano, Y.; Nagata, D. 2015: Comparison of benefits to non-dialysis CKD patients between darbepoetin alpha and epoetin beta pegol Nihon Jinzo Gakkai Shi 57(7): 1233-1240Cueto-Manzano, A.M.; Rojas-Campos, E.; Martínez-Ramírez, H.éc.R.; Valera-González, I.; Medina, M.; Monteón, F.; Ruiz, N.; Becerra, M.; Palomeque, M.A.; Cortés-Sanabria, L. 2006: Can the inflammation markers of patients with high peritoneal permeability on continuous ambulatory peritoneal dialysis be reduced on nocturnal intermittent peritoneal dialysis? Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 26(3): 341-348
Veys, N.; Dhondt, A.; Lameire, N. 1998: Pain at the injection site of subcutaneously administered erythropoietin: phosphate-buffered epoetin alpha compared to citrate-buffered epoetin alpha and epoetin beta Clinical Nephrology 49(1): 41-44
Pietrzak, I.; Baczyk, K.; Ksiazek, P. 1995: Thiamine blood level and erythrocyte transketolase activity in continuous ambulatory peritoneal dialysis and intermittent peritoneal dialysis patients Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 50: 197-203
Kanjanabuch, T.; Puttipittayathorn, N.; Leelahavanichkul, A.; Lieusuwan, S.; Katavetin, P.; Mahatanan, N.; Sriudom, K.; Chirananthavat, T.; Thongbor, N.; Eiam-Ong, S. 2011: Exfoliated mesothelial cell and CA-125 in automated peritoneal dialysis (APD) and continuous ambulatory peritoneal dialysis (CAPD) patients Journal of the Medical Association of Thailand 94(Suppl 4): S119-S125
Oba, I.; Mori, T.; Chida, M.; Kurasawa, N.; Naganuma, E.; Sato, E.; Koizumi, K.; Sato, S.; Tsuchikawa, M.; Ito, S. 2015: Glucose and Insulin Response to Peritoneal Dialysis Fluid in Diabetic and Nondiabetic Peritoneal Dialysis Patients Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 31: 11-16
Fourtounas, C.; Savidaki, E.; Roumelioti, M.; Dousdampanis, P.; Hardalias, A.; Kalliakmani, P.; Papachristou, E.; Drakopoulos, A.; Goumenos, D.S.; Vlachojannis, J.G. 2006: Acid-base profile and predictors of metabolic acidosis in patients undergoing peritoneal dialysis with lactate- and bicarbonate-buffered peritoneal dialysis solutions Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 22: 187-191
Fein, P.A.; Fazil, I.; Rafiq, M.A.; Schloth, T.; Matza, B.; Chattopadhyay, J.; Avram, M.M. 2006: Relationship of peritoneal transport rate and dialysis adequacy with inflammation in peritoneal dialysis patients Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 22: 2-6
Krack, G.; Viglino, G.; Cavalli, P.L.; Gandolfo, C.; Magliano, G.; Cantaluppi, A.; Peluso, F. 1992: Intraperitoneal administration of phosphatidylcholine improves ultrafiltration in continuous ambulatory peritoneal dialysis patients Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 12(4): 359-364
Juergensen, P.H.; Murphy, A.L.; Pherson, K.A.; Chorney, W.S.; Kliger, A.S.; Finkelstein, F.O. 1999: Tidal peritoneal dialysis to achieve comfort in chronic peritoneal dialysis patients Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 15: 125-126
Naiki, Y.; Maeda, Y.; Matsuo, K.; Yonekawa, S.; Sakaguchi, M.; Iwamoto, I.; Hasegawa, H.; Kanamaru, A. 2003: Involvement of TGF-beta signal for peritoneal sclerosing in continuous ambulatory peritoneal dialysis Journal of Nephrology 16(1): 95-102
Martin-Lester, M. 1996: Epoetin alfa--focus on the rehabilitation of dialysis patients. Case study of the anemic patient Anna Journal 23(6): 630-633
Lui, S.F.; Law, C.B.; Ting, S.M.; Li, P.; Lai, K.N. 1991: Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis Clinical Nephrology 36(5): 246-251
Eguchi, A.; Tsuchiya, K.; Tsukada, M.; Nitta, K. 2010: Clinical usefulness of reticulocyte hemoglobin equivalent (RET-He) in patients at the pre-dialysis stage and in patients on peritoneal dialysis Nihon Jinzo Gakkai Shi 52(2): 132-140
Notsuka, T.; Furusawa, M.; Tomoda, H.; Seo, Y.; Kurashige, S.; Kameda, K.; Sonoda, T. 1986: Intraperitoneal administration of beta-interferon in gastric cancer patients with peritoneal recurrence (ascites and serum IFN levels and its antitumor effect) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(12): 3538-3540
Cornes, P.; Boiangiu, I. 2007: The role of epoetin beta in the treatment of anaemia in patients with gynaecological malignancies Anticancer Research 27(1b): 513-522
Koch, K.M.; Koene, R.A.; Messinger, D.; Quarder, O.; Scigalla, P. 1995: The use of epoetin beta in anemic predialysis patients with chronic renal failure Clinical Nephrology 44(3): 201-208
Li, P.K.-T.; Chung, K.Y.; Chow, K.M. 2007: Continuous ambulatory peritoneal dialysis is better than automated peritoneal dialysis as first-line treatment in renal replacement therapy Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 27(Suppl 2): S153-S157
Hassan, K.; Hassan, F.; Hassan, D.; Edgem, R.; Hassan, S. 2015: Do diabetic patients receiving conventional dialysis solutions benefit from peritoneal dialysis? Minerva Urologica e Nefrologica 67(4): 365-374
Aguilera, A.; Bajo, M.A.; Codoceo, R.; Mariano, M.; del Peso, G.D.; Olveira, A.; Millán, I.; Gómez-Cerezo, J.; Selgas, R. 2000: Protein-losing enteropathy is associated with peritoneal functional abnormalities in peritoneal dialysis patients Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 20(3): 284-289